Inari Medical Inc. (NASDAQ:NARI) saw a downside of -2.96% to close Friday at $78.70 after subtracting -$2.4 on the day. The 5-day average trading volume is 418,100 shares of the company’s common stock. It has gained $83.87 in the past week and touched a new high 1 time within the past 5 days. An average of 576,725 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 585,364.
NARI’s 1-month performance is -4.44% or -$3.66 on its low of $74.37 reached on 09/21/21. The company’s shares have touched a 52-week low of $58.66 and high of $127.42, with the stock’s rally to the 52-week high happening on 03/11/21. YTD, NARI has lost -9.84% or -$8.59 and has reached a new high 18 times. However, the current price is down -38.24%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Sep 27, 5 days have gone by since the last insider trading activity for Inari Medical Inc. (NARI). Tu Thomas (Chief Medical Officer) most recently sold 5,000 shares at $82.86 per share on Sep 27. This transaction cost the insider $414,311. Chief Operating Officer, Hykes Andrew, sold 9,000 shares at a price of $80.75 on Sep 17. Then, on Sep 10, Director MILDER DONALD B sold 7,000 shares at a price of $81.02 per share. This transaction amounted to $567,167.
The company’s PE ratio for the last five years has touched a high of 1519.84 and a low of 158.42. NARI stock has a beta of 0.00. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 18.60 while the price-to-book (PB) in the most recent quarter is 17.61, with the price to cash flow ratio at 403.34.
Inari Medical Inc.’s quick ratio for the period ended June 29 was 6.70, with the current ratio over the same period at 7.20 meaning that NARI stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.00, while the total debt to equity was 0.00. In terms of profitability, the gross margin trailing 12 months is 92.10%The trailing 12-month EBITDA margin is 15.04% while for the period ending June 29; Inari Medical Inc.’s operating margin was 12.20%. The firm’s gross profit as reported stood at $126.56 million against revenue of $139.67 million.
The effectiveness of a company’s management is also important for investors when it comes to determining the potential profitability of the investment. Inari Medical Inc.’s return on assets over the past 12 months stands at 11.00%. Return on investment over the past year is 8.90%, while its return on equity (ROE) trailing 12 months is 12.10%. In comparison, the average ROE for the broader industry over the past year is 1.94.
For the quarterly period ending June 29 this year, Inari Medical Inc.’s cash and short-term investments amounted to $84.74 million against total debt of $0.95 million. Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 59.98% to $63.45 million, while revenue of $57.4 million was 9.54% off the previous quarter. Analysts expected NARI to announce $0.08 per share in earnings in its latest quarter, but it posted $0.07, representing a -12.50% surprise. EBITDA for the quarter stood at more than $5.01 million. NARI stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 31.74 million, with total debt at $0.95 million. Shareholders hold equity totaling $49.93 million
Let’s look briefly at Inari Medical Inc. (NARI) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 01 October was 44.90% to suggest the stock is trending Neutral, with historical volatility in this time period at 44.14%.
The stock’s 5-day moving average is $80.34, reflecting a -5.59% or -$4.66 change from its current price. NARI is currently trading -1.34% above its 20-day SMA, -14.63% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -13.05% and +14.42% respectively.
Stochastic %K and %D was 52.17% and 57.84% and the average true range (ATR) pointed at 3.69. The RSI (14) points at 45.96%, while the 14-day stochastic is at 45.06% with the period’s ATR at 3.64. The stock’s 9-day MACD Oscillator is pointing at -1.04 and -0.80 on the 14-day charts.
In the most recent analyst report for Inari Medical Inc. (NASDAQ: NARI), Wells Fargo upgraded it to an Overweight rating. They previously had an Equal weight rating on the stock. Analysts offering their rating for NARI stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate NARI as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 5 have offered a “buy” rating.
What is NARI’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $105.00 and a high of $140.00, with their median price target at $119.00. Looking at these predictions, the average price target given by analysts is for Inari Medical Inc. (NARI) stock is $119.67.